Literature DB >> 25070849

Independent of plasmacytoid dendritic cell (pDC) infection, pDC triggered by virus-infected cells mount enhanced type I IFN responses of different composition as opposed to pDC stimulated with free virus.

Theresa Frenz1, Lukas Graalmann1, Claudia N Detje1, Marius Döring1, Elena Grabski1, Stefanie Scheu2, Ulrich Kalinke3.   

Abstract

Upon treatment with vesicular stomatitis virus (VSV) particles, plasmacytoid dendritic cells (pDC) are triggered to mount substantial type I IFN responses, whereas myeloid DC (mDC) are only minor producers. Interestingly, bone marrow-derived (BM-)mDC were more vulnerable to infection with enhanced GFP (eGFP)-expressing VSV (VSVeGFP) than BM-pDC. BM-pDC stimulated with wild-type VSV mounted TLR-dependent IFN responses that were independent of RIG-I-like helicase (RLH) signaling. In contrast, in BM-pDC the VSV variant M2 induced particularly high IFN responses triggered in a TLR- and RLH-dependent manner, whereas BM-mDC stimulation was solely RLH-dependent. Importantly, VSVeGFP treatment of BM-pDC derived from IFN-β yellow fluorescent protein (YFP) reporter mice (messenger of IFN-β) resulted in YFP(+) and eGFP(+) single-positive cells, whereas among messenger of IFN-β-BM-mDC most YFP(+) cells were also eGFP(+). This observation indicated that unlike mDC, direct virus infection was not required to trigger IFN responses of pDC. VSV-infected BM-mDC triggered BM-pDC to mount significantly higher IFN responses than free virus particles. Stimulation with infected cells enhanced the percentages of pDC subsets expressing either IFN-β(+) or IFN-α6(+) plus IFN-β(+). Irrespective of whether stimulated with free virus or infected cells, IFN induction was dependent on autophagy of pDC, whereas autophagy of the infected mDC was dispensable. Collectively, these results indicated that productive VSV infection was needed to trigger IFN responses of mDC, but not of pDC, and that IFN responses were primarily induced by virus-infected cells that stimulated pDC in a TLR-dependent manner.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25070849     DOI: 10.4049/jimmunol.1400215

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  M27 expressed by cytomegalovirus counteracts effective type I interferon induction of myeloid cells but not of plasmacytoid dendritic cells.

Authors:  Marius Döring; Irina Lessin; Theresa Frenz; Julia Spanier; Annett Kessler; Pia Tegtmeyer; Franziska Dağ; Nadine Thiel; Mirko Trilling; Stefan Lienenklaus; Siegfried Weiss; Stefanie Scheu; Martin Messerle; Luka Cicin-Sain; Hartmut Hengel; Ulrich Kalinke
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

Review 2.  Interferons and viruses: an evolutionary arms race of molecular interactions.

Authors:  Hans-Heinrich Hoffmann; William M Schneider; Charles M Rice
Journal:  Trends Immunol       Date:  2015-02-20       Impact factor: 16.687

Review 3.  The multifaceted biology of plasmacytoid dendritic cells.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Nat Rev Immunol       Date:  2015-07-10       Impact factor: 53.106

4.  In Vivo Conditions Enable IFNAR-Independent Type I Interferon Production by Peritoneal CD11b+ Cells upon Thogoto Virus Infection.

Authors:  Georg Kochs; Martina Anzaghe; Stefanie Kronhart; Valentina Wagner; Patricia Gogesch; Stefanie Scheu; Stefan Lienenklaus; Zoe Waibler
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

5.  cGAS Senses Human Cytomegalovirus and Induces Type I Interferon Responses in Human Monocyte-Derived Cells.

Authors:  Jennifer Paijo; Marius Döring; Julia Spanier; Elena Grabski; Mohammed Nooruzzaman; Tobias Schmidt; Gregor Witte; Martin Messerle; Veit Hornung; Volkhard Kaever; Ulrich Kalinke
Journal:  PLoS Pathog       Date:  2016-04-08       Impact factor: 6.823

6.  STING-Licensed Macrophages Prime Type I IFN Production by Plasmacytoid Dendritic Cells in the Bone Marrow during Severe Plasmodium yoelii Malaria.

Authors:  Emily Spaulding; David Fooksman; Jamie M Moore; Alex Saidi; Catherine M Feintuch; Boris Reizis; Laurent Chorro; Johanna Daily; Grégoire Lauvau
Journal:  PLoS Pathog       Date:  2016-10-28       Impact factor: 6.823

Review 7.  Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".

Authors:  Michael Karl Melzer; Arturo Lopez-Martinez; Jennifer Altomonte
Journal:  Biomedicines       Date:  2017-02-10

8.  Immature particles and capsid-free viral RNA produced by Yellow fever virus-infected cells stimulate plasmacytoid dendritic cells to secrete interferons.

Authors:  Laura Sinigaglia; Ségolène Gracias; Elodie Décembre; Matthieu Fritz; Daniela Bruni; Nikaïa Smith; Jean-Philippe Herbeuval; Annette Martin; Marlène Dreux; Frédéric Tangy; Nolwenn Jouvenet
Journal:  Sci Rep       Date:  2018-07-18       Impact factor: 4.379

9.  Sensing of Porcine Reproductive and Respiratory Syndrome Virus-Infected Macrophages by Plasmacytoid Dendritic Cells.

Authors:  Obdulio García-Nicolás; Gaël Auray; Carmen A Sautter; Julie C F Rappe; Kenneth C McCullough; Nicolas Ruggli; Artur Summerfield
Journal:  Front Microbiol       Date:  2016-06-02       Impact factor: 5.640

Review 10.  Immune evasion of porcine enteric coronaviruses and viral modulation of antiviral innate signaling.

Authors:  Qingzhan Zhang; Dongwan Yoo
Journal:  Virus Res       Date:  2016-05-19       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.